SMTL ID : 8bxc.1 (1 other biounit)

Crystal structure of JAK2 JH1 in complex with itacitinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x S4R: Itacitinib(Non-covalent)

S4R.1: 27 residues within 4Å: Chain A: L.39, G.40, K.41, G.42, N.43, F.44, G.45, S.46, V.47, A.64, K.66, L.68, E.82, V.95, M.113, E.114, Y.115, L.116, G.119, S.120, R.164, N.165, L.167, G.177, D.178, G.180, L.181 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.44, A:V.47, A:A.64, A:L.167, A:L.167 Hydrogen bonds: A:F.44, A:G.45, A:E.114, A:L.116 Water bridges: A:K.66 Salt bridges: A:D.178 Halogen bonds: A:K.66, A:E.82

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miao, Y. et al., Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. J.Med.Chem. (2024)

Release Date

2023-12-20

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence